Sepsis-3: Insights from the Lead Author

Room type

Permanent

Name

This field is required.

Last Name

This field is required.

Email Address

This field is required.

Company

This field is required.

Required fields

Payment via

Before buying your ticket, please check the tech requirements for joining the event here.

If you have already registered and can't locate your registration confirmation email, click here!

System configuration test. Click here!

Marvyn Singer, MD

Mervyn Singer, MB BS, MD, FRCP (Lon), FRCP (Edin), FFICM, is Professor of Intensive Care Medicine and Director of the Bloomsbury Institute of Intensive Care Medicine at University College London, UK, since 2001. He was Senior Investigator at the National Institute of Health Research from 2009 to 2017 and is currently the Sepsis Topic Advisor for NICE. Dr Singer was Co-chair of the Sepsis-3 Consensus Task Force and lead author of "The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Agenda

This special session features Dr. Mervyn Singer, lead author of Sepsis-3 guidelines and co-author of the new update to SOFA, SOFA-2.

In this session, Dr. Singer:

Outlines why the Sepsis-2 SIRS criteria are now regarded as outdated and inadequate.
Describes the development process of the Sepsis-3 guidelines.
Discusses the latest revisions to the SOFA score, known as SOFA-2.
Debunks the common sepsis denial rationales presented by payers.

Recording is available for 90 days after purchase.